Literature DB >> 11381114

RNA editing activity is associated with splicing factors in lnRNP particles: The nuclear pre-mRNA processing machinery.

O Raitskin1, D S Cho, J Sperling, K Nishikura, R Sperling.   

Abstract

Multiple members of the ADAR (adenosine deaminases acting on RNA) gene family are involved in A-to-I RNA editing. It has been speculated that they may form a large multicomponent protein complex. Possible candidates for such complexes are large nuclear ribonucleoprotein (lnRNP) particles. The lnRNP particles consist mainly of four spliceosomal subunits that assemble together with the pre-mRNA to form a large particle and thus are viewed as the naturally assembled pre-mRNA processing machinery. Here we investigated the presence of ADARs in lnRNP particles by Western blot analysis using anti-ADAR antibodies and by indirect immunoprecipitation. Both ADAR1 and ADAR2 were found associated with the spliceosomal components Sm and SR proteins within the lnRNP particles. The two ADARs, associated with lnRNP particles, were enzymatically active in site-selective A-to-I RNA editing. We demonstrate the association of ADAR RNA editing enzymes with physiological supramolecular complexes, the lnRNP particles.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11381114      PMCID: PMC34394          DOI: 10.1073/pnas.111153798

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

Review 1.  Flipping the switch to an active spliceosome.

Authors:  H L Murray; K A Jarrell
Journal:  Cell       Date:  1999-03-05       Impact factor: 41.582

2.  Automated electron tomography of large nuclear RNP (InRNP) particles--the naturally assembled complexes of precursor messenger RNA and splicing factors.

Authors:  O Medalia; A J Koster; A Tocilij; M Angenitzki; J Sperling; Z Berkovitch-Yellin; R Sperling
Journal:  J Struct Biol       Date:  1997-12       Impact factor: 2.867

Review 3.  Protein functions in pre-mRNA splicing.

Authors:  C L Will; R Lührmann
Journal:  Curr Opin Cell Biol       Date:  1997-06       Impact factor: 8.382

4.  Three-dimensional image reconstruction of large nuclear RNP (lnRNP) particles by automated electron tomography.

Authors:  R Sperling; A J Koster; C Melamed-Bessudo; A Rubinstein; M Angenitzki; Z Berkovitch-Yellin; J Sperling
Journal:  J Mol Biol       Date:  1997-04-04       Impact factor: 5.469

5.  RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity.

Authors:  C M Niswender; S C Copeland; K Herrick-Davis; R B Emeson; E Sanders-Bush
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

6.  Two forms of human double-stranded RNA-specific editase 1 (hRED1) generated by the insertion of an Alu cassette.

Authors:  A Gerber; M A O'Connell; W Keller
Journal:  RNA       Date:  1997-05       Impact factor: 4.942

7.  Regulation of serotonin-2C receptor G-protein coupling by RNA editing.

Authors:  C M Burns; H Chu; S M Rueter; L K Hutchinson; H Canton; E Sanders-Bush; R B Emeson
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

8.  Editing of glutamate receptor B subunit ion channel RNAs by four alternatively spliced DRADA2 double-stranded RNA adenosine deaminases.

Authors:  F Lai; C X Chen; K C Carter; K Nishikura
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

9.  A supraspliceosome model for large nuclear ribonucleoprotein particles based on mass determinations by scanning transmission electron microscopy.

Authors:  S Müller; B Wolpensinger; M Angenitzki; A Engel; J Sperling; R Sperling
Journal:  J Mol Biol       Date:  1998-10-23       Impact factor: 5.469

10.  The RNA-editing enzyme ADAR1 is localized to the nascent ribonucleoprotein matrix on Xenopus lampbrush chromosomes but specifically associates with an atypical loop.

Authors:  C R Eckmann; M F Jantsch
Journal:  J Cell Biol       Date:  1999-02-22       Impact factor: 10.539

View more
  45 in total

Review 1.  The challenge of target sequence specificity in C-->U RNA editing.

Authors:  Nicholas O Davidson
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

2.  Coordination of editing and splicing of glutamate receptor pre-mRNA.

Authors:  Eva Bratt; Marie Ohman
Journal:  RNA       Date:  2003-03       Impact factor: 4.942

3.  Widespread RNA editing of embedded alu elements in the human transcriptome.

Authors:  Dennis D Y Kim; Thomas T Y Kim; Thomas Walsh; Yoshifumi Kobayashi; Tara C Matise; Steven Buyske; Abram Gabriel
Journal:  Genome Res       Date:  2004-09       Impact factor: 9.043

4.  Modulation of RNA editing by functional nucleolar sequestration of ADAR2.

Authors:  Christopher L Sansam; K Sam Wells; Ronald B Emeson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-11       Impact factor: 11.205

5.  A potential role for initiator-tRNA in pre-mRNA splicing regulation.

Authors:  Eyal Kamhi; Oleg Raitskin; Ruth Sperling; Joseph Sperling
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

Review 6.  Adenosine deaminases acting on RNA, RNA editing, and interferon action.

Authors:  Cyril X George; Zhenji Gan; Yong Liu; Charles E Samuel
Journal:  J Interferon Cytokine Res       Date:  2010-12-23       Impact factor: 2.607

Review 7.  Brain-specific small nucleolar RNAs.

Authors:  Boris Rogelj
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

8.  Substrate-dependent contribution of double-stranded RNA-binding motifs to ADAR2 function.

Authors:  Ming Xu; K Sam Wells; Ronald B Emeson
Journal:  Mol Biol Cell       Date:  2006-05-03       Impact factor: 4.138

Review 9.  ADARs: viruses and innate immunity.

Authors:  Charles E Samuel
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

10.  Positive correlation between ADAR expression and its targets suggests a complex regulation mediated by RNA editing in the human brain.

Authors:  Noa Liscovitch; Lily Bazak; Erez Y Levanon; Gal Chechik
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.